{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:39:39Z","timestamp":1769279979448,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007048","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EClinicalMedicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.eclinm.2021.101102","type":"journal-article","created":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T07:00:58Z","timestamp":1630306858000},"page":"101102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"special_numbering":"C","title":["Casirivimab\u2013Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5248-0227","authenticated-orcid":false,"given":"Raymund R.","family":"Razonable","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Pawlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"O'Horo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori L.","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4723-689X","authenticated-orcid":false,"given":"Richard","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis M.","family":"Bierle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly Destro","family":"Borgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2517-638X","authenticated-orcid":false,"given":"Sara N.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle C.","family":"Hedin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Lenehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Puranik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria T","family":"Seville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leigh L.","family":"Speicher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidna M.","family":"Tulledge-Scheitel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AJ","family":"Venkatakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline G.","family":"Wilker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Badley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra","family":"Ganesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eclinm.2021.101102_bib0001","article-title":"An EUA for bamlanivimab-a monoclonal antibody for COVID-19","year":"2020","journal-title":"JAMA"},{"issue":"1614","key":"10.1016\/j.eclinm.2021.101102_bib0002","first-page":"201","article-title":"An EUA for casirivimab and imdevimab for COVID-19","volume":"62","year":"2020","journal-title":"Med Lett Drugs Ther"},{"issue":"1621","key":"10.1016\/j.eclinm.2021.101102_bib0003","first-page":"49","article-title":"An EUA for bamlanivimab and etesevimab for COVID-19","volume":"63","year":"2021","journal-title":"Med Lett Drugs Ther"},{"issue":"9","key":"10.1016\/j.eclinm.2021.101102_bib0004","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101102_bib0005","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19","volume":"384","author":"Weinreich","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2021.101102_bib0006","unstructured":"Bhimraj A, Morgan R, Schumaker AH, et\u00a0al. Infectious diseases society of America guidelines on the treatment and management of patients with COVID-19. Available at: https:\/\/www.idsociety.org\/practice-guideline\/covid-19-guideline-treatment-and-management\/. Accessed 05\/10\/ 2021."},{"key":"10.1016\/j.eclinm.2021.101102_bib0007","unstructured":"NIH. Anti-SARS-CoV-2 monoclonal antibodies. Available at: https:\/\/www.covid19treatmentguidelines.nih.gov\/anti-sars-cov-2-antibody-products\/anti-sars-cov-2-monoclonal-antibodies\/. Accessed May 10, 2021."},{"key":"10.1016\/j.eclinm.2021.101102_bib0008","series-title":"A framework for outpatient infusion of anti-spike monoclonal antibodies to high-risk patients with mild to moderate coronavirus disease-19: the mayo clinic model","author":"Razonable","year":"2021"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101102_bib0009","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1467-6419.2007.00527.x","article-title":"Some practical guidance for the implementation of propensity score matching","volume":"22","author":"Caliendo","year":"2008","journal-title":"J Econ Surv"},{"issue":"6","key":"10.1016\/j.eclinm.2021.101102_bib0010","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1093\/ije\/dyy120","article-title":"Evaluating large-scale propensity score performance through real-world and synthetic data experiments","volume":"47","author":"Tian","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.eclinm.2021.101102_bib0011","series-title":"Applied survival analysis: regression modeling of time-to-event data","author":"Hosmer","year":"2008"},{"key":"10.1016\/j.eclinm.2021.101102_bib0012","unstructured":"Davidson-Pilon C, Kalderstam J, Zivich P, et\u00a0al. CamDavidsonPilon\/lifelines: v0. 21.3. Zenodo 2019."},{"issue":"20","key":"10.1016\/j.eclinm.2021.101102_bib0013","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"10229","key":"10.1016\/j.eclinm.2021.101102_bib0014","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.eclinm.2021.101102_bib0015","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19","volume":"384","author":"Chen","year":"2021","journal-title":"N Engl J Med"},{"issue":"9s","key":"10.1016\/j.eclinm.2021.101102_bib0016","article-title":"Telemedicine consultations and follow-up of patients with COVID-19","volume":"95","author":"Crane","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.eclinm.2021.101102_bib0017","first-page":"118","article-title":"Managing patients in the COVID-19 pandemic: a virtual multidisciplinary approach","volume":"5","author":"Ganesh","year":"2021","journal-title":"Mayo Clinic Proc: Innovat, Qual Outcomes"},{"key":"10.1016\/j.eclinm.2021.101102_bib0018","series-title":"Outcomes of COVID-19 with the mayo clinic model of care and research","author":"O'Horo","year":"2020"},{"issue":"19","key":"10.1016\/j.eclinm.2021.101102_bib0019","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19 - final report","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.eclinm.2021.101102_bib0020","first-page":"693","article-title":"Dexamethasone in hospitalized patients with Covid-19 - preliminary report","volume":"384","author":"Group","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eclinm.2021.101102_bib0021","article-title":"Trends in mortality of hospitalised COVID-19 patients: a single centre observational cohort study from Spain","volume":"3","author":"Garcia-Vidal","year":"2021","journal-title":"Lancet Reg Health Eur"},{"issue":"2","key":"10.1016\/j.eclinm.2021.101102_bib0022","doi-asserted-by":"crossref","first-page":"90","DOI":"10.12788\/jhm.3552","article-title":"Trends in COVID-19 risk-adjusted mortality rates","volume":"16","author":"Horwitz","year":"2021","journal-title":"J Hosp Med"},{"key":"10.1016\/j.eclinm.2021.101102_bib0023","unstructured":"Medicine JHU. Coronavirus resource center. Available at: https:\/\/coronavirus.jhu.edu\/. Accessed 06\/02\/ 2021."}],"container-title":["EClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021003825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537021003825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T19:09:14Z","timestamp":1762888154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537021003825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":23,"alternative-id":["S2589537021003825"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101102","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Casirivimab\u2013Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19","name":"articletitle","label":"Article Title"},{"value":"EClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2021.101102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101102"}}